Scn3B — Sodium Channel Beta 3 Subunit is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Gene Symbol | SCN3B |
| Full Name | Sodium Channel Voltage-Gated Beta Subunit 3 |
| Chromosome | 11q24.1 |
| NCBI Gene ID | 6329 |
| OMIM | 608389 |
| Ensembl ID | ENSG00000166262 |
| UniProt ID | Q9NY72 |
| Associated Diseases | Epilepsy, Autism Spectrum Disorder |
The SCN3B gene encodes the voltage-gated sodium channel beta-3 subunit (Navβ3), an auxiliary subunit that plays a critical role in modulating sodium channel function, trafficking, and neuronal excitability. Located on chromosome 11q24.1, SCN3B is expressed primarily in the central nervous system, with high expression in the cerebral cortex, hippocampus, and cerebellum. The protein contains an extracellular immunoglobulin-like domain and a transmembrane segment, characteristic of all voltage-gated sodium channel beta subunits.
The beta-3 subunit modulates channel gating properties, influences channel trafficking to the plasma membrane, and plays important roles in action potential initiation and propagation. Mutations in SCN3B have been implicated in neurological disorders including epilepsy and autism spectrum disorder, highlighting the importance of proper sodium channel regulation in neural circuit function.
SCN3B encodes the beta-3 subunit of the voltage-gated sodium channel (Nav). This auxiliary subunit modulates channel gating, trafficking, and expression at the plasma membrane. Like other beta subunits (SCN1B, SCN2B, SCN3B), it contains an extracellular immunoglobulin-like domain and a transmembrane segment.
In neurons, the beta-3 subunit influences sodium channel function and neuronal excitability. It plays roles in action potential propagation, dendritic integration, and synaptic integration.
Expressed in the brain with high levels in cortex, hippocampus, and cerebellum. SCN3B is particularly expressed in excitatory neurons.
| Disease | Variants | Inheritance | Mechanism |
|---|---|---|---|
| Epilepsy | R28L, R89Q | De novo | Altered neuronal excitability |
| Autism Spectrum Disorder | — | Risk factor | Impaired synaptic function |
The study of Scn3B — Sodium Channel Beta 3 Subunit has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.